Ardelyx Investigative Site 122 — Little Rock, Arkansas

Ardelyx Investigative Site 122 is a clinical research site located in Little Rock, Arkansas, United States 72212.

Crixeo Health Trust Score: 53/100 (POOR). This profile has not yet been claimed by the site owner.

Ardelyx Investigative Site 122 has participated in 2 clinical trials.

Therapeutic areas: Constipation Predominant Irritable Bowel Syndrome.

Sponsors: Ardelyx.

Sponsor Feasibility Report

Trust Score: 53/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Ardelyx Investigative Site 122?

Ardelyx Investigative Site 122 has a Crixeo Trust Score of 53/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Ardelyx Investigative Site 122 conducted?

Ardelyx Investigative Site 122 has 2 clinical trials on record. Their work covers Constipation Predominant Irritable Bowel Syndrome.

Is Ardelyx Investigative Site 122 accredited by Crixeo Health?

Ardelyx Investigative Site 122 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Ardelyx Investigative Site 122?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.